General Information


DRACP ID  DRACP01990

Peptide Name  

Sequence  YIWARAERVWLWWGKFLSL

Sequence Length  19

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP Membrane-targeted



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
MCF-7 Invasive breast carcinoma of no special type Carcinoma EC50=56±3 µM Not available Not available 1

Hemolytic Activity  Human erythrocytes: Not active up to 400 µM

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  DRACP01990

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C125H174N30O24

Absent amino acids  CDHMNPQT

Common amino acids  W

Mass  280219

Pl  10.45

Basic residues  3

Acidic residues  1

Hydrophobic residues  12

Net charge  2

Boman Index  -516

Hydrophobicity  21.05

Aliphatic Index  107.89

Half Life 
  Mammalian: 1.3 hour
  Yeast: 3 min
  E.coli: 2 min

Extinction Coefficient cystines  23490

Absorbance 280nm  1305

Polar residues  3

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 29679519

Title  Designing Anticancer Peptides by Constructive Machine Learning

Doi 10.1002/cmdc.201800204

Year  2018

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  DBAASPS_14292

DRACP is developed by Dr.Zheng's team.